2L
AXNX

25 LLC’s Axonics, Inc. Common Stock AXNX Stock Holding History

25 LLC’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10
Closed -$505 – 600
2023
Q2 		$505 Buy
+10
New +$532 ﹤0.01% 531

Other funds holding AXNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

25 LLC's AXNX Position: Q3 2023 in Review

25 LLC sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2023, closing a stake of 10 shares — an estimated $505 sold.

25 LLC first reported a position in AXNX in Q2 2023 and held it in 1 quarter. The position peaked at $505 in Q2 2023. 221 funds tracked by Wall St. Rank hold AXNX as of Q3 2023.

  • 25 LLC reported no remaining Axonics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • 25 LLC sold 10 Axonics, Inc. Common Stock shares in Q3 2023, an estimated $505.
  • 25 LLC first reported a position in Axonics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • 25 LLC's Axonics, Inc. Common Stock position peaked at $505 in Q2 2023.
  • 221 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2023.

Based on 25 LLC's 13F filing for Q3 2023, filed 18 Oct 2023.